CRYOMASS TECHNOLOGIES |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0363 USD | -5.98% |
|
-7.87% | -14.99% |
Valuation
| Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 0.3476 | 0.382 | 67.47 | 19.05 | 53.18 | 37.51 |
| Enterprise Value (EV) 1 | 0.3475 | 0.1747 | 65.55 | 19.19 | 47.58 | 37.49 |
| P/E ratio | -6.13 x | -0.5 x | -18.8 x | -1.68 x | -3.31 x | -3.57 x |
| Yield | - | - | - | - | - | - |
| Capitalization / Revenue | - | - | 19,395,430 x | 24,378,156 x | - | - |
| EV / Revenue | - | - | 18,842,774 x | 24,550,660 x | - | - |
| EV / EBITDA | - | -520,066 x | -22,801,730 x | -3,002,797 x | -5,986,375 x | -3,692,308 x |
| EV / FCF | 14.2 x | -0.22 x | -62.4 x | 6.13 x | 30.1 x | -6.16 x |
| FCF Yield | 7.03% | -460% | -1.6% | 16.3% | 3.32% | -16.2% |
| Price to Book | -1.96 x | 0.59 x | 5.46 x | 5.35 x | 3.93 x | 8.2 x |
| Nbr of stocks (in thousands) | 69,520 | 76,400 | 105,427 | 95,731 | 196,950 | 202,651 |
| Reference price 2 | 0.005000 | 0.005000 | 0.6400 | 0.1990 | 0.2700 | 0.1851 |
| Announcement Date | 5/1/18 | 5/24/19 | 4/3/20 | 3/30/21 | 3/28/22 | 3/24/23 |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|
| Net sales | - | - | 3.479 | 0.7815 | - | - |
| EBITDA | - | -0.3359 | -2.875 | -6.389 | -7.948 | -10.15 |
| EBIT 1 | -0.0519 | -0.3366 | -3.021 | -6.535 | -7.992 | -10.31 |
| Operating Margin | - | - | -86.83% | -836.24% | - | - |
| Earnings before Tax (EBT) 1 | -0.0568 | -0.4275 | -3.031 | -6.86 | -10.13 | -10.44 |
| Net income 1 | -0.0568 | -0.4275 | -3.058 | -11.82 | -12.86 | -10.42 |
| Net margin | - | - | -87.89% | -1,512.04% | - | - |
| EPS 2 | -0.000816 | -0.009999 | -0.0340 | -0.1183 | -0.0816 | -0.0519 |
| Free Cash Flow 1 | 0.0244 | -0.8038 | -1.051 | 3.13 | 1.578 | -6.09 |
| FCF margin | - | - | -30.22% | 400.59% | - | - |
| FCF Conversion (EBITDA) | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - |
| Announcement Date | 5/1/18 | 5/24/19 | 4/3/20 | 3/30/21 | 3/28/22 | 3/24/23 |
1USD in Million2USD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | 0.13 | - | - |
| Net Cash position 1 | 0 | 0.21 | 1.92 | - | 5.6 | 0.02 |
| Leverage (Debt/EBITDA) | - | - | - | -0.0211 x | - | - |
| Free Cash Flow 1 | 0.02 | -0.8 | -1.05 | 3.13 | 1.58 | -6.09 |
| ROE (net income / shareholders' equity) | 38.2% | -182% | -42.2% | -82.3% | -118% | -115% |
| ROA (Net income/ Total Assets) | -55,898% | -59.8% | -22.5% | -34.7% | -42.7% | -55% |
| Assets 1 | 0.000102 | 0.7148 | 13.58 | 34.08 | 30.1 | 18.96 |
| Book Value Per Share 2 | -0 | 0.0100 | 0.1200 | 0.0400 | 0.0700 | 0.0200 |
| Cash Flow per Share 2 | 0 | 0 | 0.0300 | 0 | 0.0300 | 0.0100 |
| Capex | - | 0.46 | 0.04 | - | 1.23 | 0.3 |
| Capex / Sales | - | - | 1.09% | - | - | - |
| Announcement Date | 5/1/18 | 5/24/19 | 4/3/20 | 3/30/21 | 3/28/22 | 3/24/23 |
1USD in Million2USD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
- Stock Market
- Equities
- CRYM Stock
- Financials Cryomass Technologies
